Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

Weekly Picks

SILO logo
Silo Pharma
CM
CMCVentures
Community Contributor

Groundbreaking therapies that could change the treatment landscape for PTSD, fibromyalgia, MS & Alzheimer’s

Key Takeaways Silo Pharma is advancing a diversified pipeline of innovative therapies aimed at major health challenges in Central Nervous System (CNS) disorders like PTSD, fibromyalgia, Alzheimer’s, and multiple sclerosis (MS). The company’s unique approach of combining traditional drugs with psychedelic-inspired therapies positions it to address significant gaps in the treatment landscape.
View narrative
US$6.20
FV
86.9% undervalued intrinsic discount
234.00%
Revenue growth p.a.
7users have liked this narrative
0users have commented on this narrative
26users have followed this narrative
8 days ago author updated this narrative
DOCN logo
DigitalOcean Holdings
NE
Nenad
Community Contributor

DigitalOcean Will Grow 14% by Embracing AI with Paperspace Acquisition

1. Current Business (Present Narrative): DigitalOcean is a cloud computing provider focused on small and medium-sized businesses (SMBs) , startups, and developers.
View narrative
US$50.00
FV
42.8% undervalued intrinsic discount
18.62%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
23users have followed this narrative
4 months ago author updated this narrative

Community Investing Ideas

Load previous narratives
TUYA logo
Tuya
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts

Advancing AI, Hardware And Ecosystems Will Shape Our Future

Key Takeaways Expansion into hardware solutions and AI R&D could drive smart device penetration and boost revenue growth across various sectors. Focus on global AIoT ecosystem and strategic international expansion is key for sustained competitive advantages and revenue growth.
View narrative
US$4.10
FV
44.1% undervalued intrinsic discount
18.30%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
7 days ago author updated this narrative
RIG logo
Transocean
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts

New Barents And Invictus Programs Will Advance Efficiency

Key Takeaways Transocean's strong backlog and operational efficiency improvements suggest enhanced revenue, margins, and earnings. A robust demand outlook and cost-saving initiatives are set to boost revenue growth and long-term prospects.
View narrative
US$4.33
FV
46.9% undervalued intrinsic discount
3.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
24users have followed this narrative
7 days ago author updated this narrative
IVVD logo
Invivyd
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts

Pemivibart And Next-Generation VYD2311 Will Empower Market Expansion By 2025

Key Takeaways The development of next-generation antibodies could expand market reach and improve margins by lowering production and administration costs. Efforts to engage with the scientific community and regulators may restore trust, enhancing future earnings and market potential.
View narrative
US$6.60
FV
91.1% undervalued intrinsic discount
173.47%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
32users have followed this narrative
7 days ago author updated this narrative
NEU logo
Neuren Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts

DAYBUE And NNZ-2591 Will Expand Markets While Facing Regulatory Risks

Key Takeaways Strong financial position and partnerships reduce the need for capital raising, protecting margins and earnings. International expansion and R&D investments present significant long-term growth and valuation opportunities.
View narrative
AU$24.97
FV
49.5% undervalued intrinsic discount
-12.12%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
42users have followed this narrative
7 days ago author updated this narrative